{"id":479798,"date":"2021-04-21T16:04:11","date_gmt":"2021-04-21T20:04:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/"},"modified":"2021-04-21T16:04:11","modified_gmt":"2021-04-21T20:04:11","slug":"freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/","title":{"rendered":"Freeline to Participate in Upcoming Investor Conferences in April and May 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">LONDON, April  21, 2021  (GLOBE NEWSWIRE) &#8212; Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the \u201cCompany\u201d or \u201cFreeline\u201d), a clinical-stage biotechnology company developing transformative AAV-mediated gene therapies for patients suffering from inherited systemic debilitating diseases today announced participation in the following virtual investor conferences:<\/p>\n<ul type=\"disc\">\n<li>Chardan\u2019s 5<sup>th<\/sup> Annual Genetic Medicines Manufacturing Summit on April 26, 2021, where senior management will give a Company presentation at 9:45 am ET.\n<\/li>\n<li>7<sup>th <\/sup>Annual Truist Securities 2021 Life Sciences Summit on May 4, 2021, where senior management will participate in virtual one-on-one meetings with investors.<\/li>\n<\/ul>\n<p>The Company presentation from Chardan\u2019s 5<sup>th<\/sup> Annual Genetic Medicines Manufacturing Summit will be available on the investors section of the Freeline website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aG-xnt05OWdEmUpK1rGi9hQJnJ6Us_FzjgzFRV5JdF3l959u-GDZG1P7XlXzIu2eF4EX_W-Kif3lLkvC0NmW862QNGlnuH0uBqt7UiPcuKNpVartvh9kyW8fqH_rEP5q\" rel=\"nofollow noopener\" target=\"_blank\">Freeline.life<\/a>.<\/p>\n<p>\n        <strong>About Freeline Therapeutics<\/strong>\n      <\/p>\n<p>Freeline is a clinical-stage biotechnology company developing transformative adeno-associated virus (\u201cAAV\u201d) vector-mediated systemic gene therapies. The Company is dedicated to improving patient lives through innovative, one-time treatments that provide functional cures for inherited systemic debilitating diseases. Freeline uses its proprietary, rationally-designed AAV vector, along with novel promoters and transgenes, to deliver a functional copy of a therapeutic gene into human liver cells, thereby expressing a persistent functional level of the missing protein into the patient\u2019s bloodstream. The Company\u2019s integrated gene therapy platform includes in-house capabilities in research, clinical development, manufacturing and commercialization. The Company has clinical programs in Hemophilia B and Fabry disease, as well as preclinical programs in Gaucher disease and Hemophilia A. Freeline is headquartered in the UK and has operations in Germany and the US.<\/p>\n<p>\n        <strong>Contact <\/strong>\n      <\/p>\n<p>David S. Arrington<br \/>Vice President Investor Relations &amp; Corporate Communications<br \/>Freeline Therapeutics<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nVc57KgzYtYtngXK8KFhW5Ku0__hNcwUjH3p0Gwr-GHAgMOmxrPg0BInEa-phGmcpfU8eEmcDhl8cKiFPiSWIBjE2DGnXBgrHiPuV0wry1MF_kPsKMUc8Dz30T-o18Xs\" rel=\"nofollow noopener\" target=\"_blank\">david.arrington@freeline.life<\/a><br \/>+1 (646) 668 6947<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyMTEwOSM0MTMxOTczIzIyMDAzNjk=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/703ce119-18a3-4bf8-8a88-73081701bbf3\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LONDON, April 21, 2021 (GLOBE NEWSWIRE) &#8212; Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the \u201cCompany\u201d or \u201cFreeline\u201d), a clinical-stage biotechnology company developing transformative AAV-mediated gene therapies for patients suffering from inherited systemic debilitating diseases today announced participation in the following virtual investor conferences: Chardan\u2019s 5th Annual Genetic Medicines Manufacturing Summit on April 26, 2021, where senior management will give a Company presentation at 9:45 am ET. 7th Annual Truist Securities 2021 Life Sciences Summit on May 4, 2021, where senior management will participate in virtual one-on-one meetings with investors. The Company presentation from Chardan\u2019s 5th Annual Genetic Medicines Manufacturing Summit will be available on the investors section of the Freeline website at Freeline.life. About Freeline Therapeutics Freeline is a clinical-stage &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Freeline to Participate in Upcoming Investor Conferences in April and May 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-479798","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Freeline to Participate in Upcoming Investor Conferences in April and May 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Freeline to Participate in Upcoming Investor Conferences in April and May 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LONDON, April 21, 2021 (GLOBE NEWSWIRE) &#8212; Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the \u201cCompany\u201d or \u201cFreeline\u201d), a clinical-stage biotechnology company developing transformative AAV-mediated gene therapies for patients suffering from inherited systemic debilitating diseases today announced participation in the following virtual investor conferences: Chardan\u2019s 5th Annual Genetic Medicines Manufacturing Summit on April 26, 2021, where senior management will give a Company presentation at 9:45 am ET. 7th Annual Truist Securities 2021 Life Sciences Summit on May 4, 2021, where senior management will participate in virtual one-on-one meetings with investors. The Company presentation from Chardan\u2019s 5th Annual Genetic Medicines Manufacturing Summit will be available on the investors section of the Freeline website at Freeline.life. About Freeline Therapeutics Freeline is a clinical-stage &hellip; Continue reading &quot;Freeline to Participate in Upcoming Investor Conferences in April and May 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-21T20:04:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyMTEwOSM0MTMxOTczIzIyMDAzNjk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Freeline to Participate in Upcoming Investor Conferences in April and May 2021\",\"datePublished\":\"2021-04-21T20:04:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\\\/\"},\"wordCount\":267,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyMTEwOSM0MTMxOTczIzIyMDAzNjk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\\\/\",\"name\":\"Freeline to Participate in Upcoming Investor Conferences in April and May 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyMTEwOSM0MTMxOTczIzIyMDAzNjk=\",\"datePublished\":\"2021-04-21T20:04:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyMTEwOSM0MTMxOTczIzIyMDAzNjk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyMTEwOSM0MTMxOTczIzIyMDAzNjk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Freeline to Participate in Upcoming Investor Conferences in April and May 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Freeline to Participate in Upcoming Investor Conferences in April and May 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/","og_locale":"en_US","og_type":"article","og_title":"Freeline to Participate in Upcoming Investor Conferences in April and May 2021 - Market Newsdesk","og_description":"LONDON, April 21, 2021 (GLOBE NEWSWIRE) &#8212; Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the \u201cCompany\u201d or \u201cFreeline\u201d), a clinical-stage biotechnology company developing transformative AAV-mediated gene therapies for patients suffering from inherited systemic debilitating diseases today announced participation in the following virtual investor conferences: Chardan\u2019s 5th Annual Genetic Medicines Manufacturing Summit on April 26, 2021, where senior management will give a Company presentation at 9:45 am ET. 7th Annual Truist Securities 2021 Life Sciences Summit on May 4, 2021, where senior management will participate in virtual one-on-one meetings with investors. The Company presentation from Chardan\u2019s 5th Annual Genetic Medicines Manufacturing Summit will be available on the investors section of the Freeline website at Freeline.life. About Freeline Therapeutics Freeline is a clinical-stage &hellip; Continue reading \"Freeline to Participate in Upcoming Investor Conferences in April and May 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-21T20:04:11+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyMTEwOSM0MTMxOTczIzIyMDAzNjk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Freeline to Participate in Upcoming Investor Conferences in April and May 2021","datePublished":"2021-04-21T20:04:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/"},"wordCount":267,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyMTEwOSM0MTMxOTczIzIyMDAzNjk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/","name":"Freeline to Participate in Upcoming Investor Conferences in April and May 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyMTEwOSM0MTMxOTczIzIyMDAzNjk=","datePublished":"2021-04-21T20:04:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyMTEwOSM0MTMxOTczIzIyMDAzNjk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyMTEwOSM0MTMxOTczIzIyMDAzNjk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-in-upcoming-investor-conferences-in-april-and-may-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Freeline to Participate in Upcoming Investor Conferences in April and May 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/479798","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=479798"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/479798\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=479798"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=479798"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=479798"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}